CompletedNot Applicable

Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.

Turkey (Türkiye)102 participantsStarted 2022-09-01

Plain-language summary

To evaluate the effect of intravenous tranexamic acid plus intramyometrial desmopressin administration on perioperative blood loss and blood transfusion need in laparoscopic myomectomy operation.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients who are planned to undergo different surgery along with myomectomy
✕. Those with a diagnosis and suspicion of malignancy
✕. Those with a history of thromboembolic disease
✕. Those with cardiac, hepatic or renal disease
✕. Those with a body mass index of 30 and above
✕. Patients with abnormal coagulation test results
✕. Patients using anticoagulants
✕. Those who use drugs or diseases that may affect coagulation (serum creatinine \> 1.5 mg/dL)

What they're measuring

Perioperative blood loss

Timeframe: At the end of the surgery.

Preoperative and postoperative hemoglobin change

Timeframe: On postoperative day 0 and day 2

Trial details

NCT IDNCT05517590

SponsorAcibadem University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Leiomyoma, Uterine trials